Altimmune (ALT) Other Working Capital Changes (2010 - 2026)
Altimmune (ALT) posted quarterly Other Working Capital Changes of -$18885.0 for Q1 2020, down 209.95% year-over-year from $17176.0 in Q2 2019, and down 151.23% quarter-over-quarter from $36865.0 in Q4 2019.
Powered by 
Analysis
Altimmune (ALT) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Altimmune (ALT) has reported Other Working Capital Changes for 3 consecutive years, with -$18885.0 the latest figure, recorded in Q1 2020.
- In Q1 2020, Other Working Capital Changes fell 209.95% year-over-year to -$18885.0; the TTM figure through Mar 2020 stood at -$14029.0 (up 38.11% YoY), while the FY2019 annual figure was $22032.0, up 211.39% from the prior year.
- Other Working Capital Changes retreated to -$18885.0 in Q1 2020 per ALT's latest filing, from $36865.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.8 million in Q2 2023 and bottomed at -$4.0 million in Q1 2024.
- Historically, Other Working Capital Changes has averaged -$437117.6 across 5 years, with a median of -$228000.0 in 2024.
- Annual changes were most pronounced in 2019 — Other Working Capital Changes soared 845.2% — and 2020, when it slumped 209.95%.
- Altimmune's Other Working Capital Changes stood at -$4947.0 in 2018, then jumped by 845.2% to $36865.0 in 2019, then plunged by 151.23% to -$18885.0 in 2020.
- Business Quant data shows ALT's Other Working Capital Changes at -$18885.0 in Q1 2020, $36865.0 in Q4 2019, and -$17635.0 in Q3 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Altimmune | 636.07 Mn | 636.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.72 Mn |
| Jun 30, 2026 | 3.72 Mn |
| Mar 31, 2026 | -1.62 Mn |
| Mar 31, 2026 | -1.62 Mn |
| Dec 31, 2025 | -1.70 Mn |
| Dec 31, 2025 | -1.70 Mn |
| Sep 30, 2025 | 8,000.00 |
| Sep 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 1.47 Mn |
| Jun 30, 2025 | 1.47 Mn |
| Mar 31, 2025 | 428,000.00 |
| Mar 31, 2025 | 428,000.00 |
| Dec 31, 2024 | -793,000.00 |
| Dec 31, 2024 | -793,000.00 |
| Sep 30, 2024 | -228,000.00 |
| Sep 30, 2024 | -228,000.00 |
| Jun 30, 2024 | 354,000.00 |
| Jun 30, 2024 | 354,000.00 |
| Mar 31, 2024 | -4.05 Mn |
| Mar 31, 2024 | -4.05 Mn |